|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...5152535455565758596061...110111» |
- ||||| Perjeta (pertuzumab) / Roche
Enrollment closed, Combination therapy: Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) (clinicaltrials.gov) - Feb 20, 2015
P3, N=208, Active, not recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting
- Trial primary completion date: Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=20, Recruiting, Sponsor: Case Comprehensive Cancer Center
Recruiting --> Active, not recruiting Trial primary completion date: Nov 2014 --> Aug 2015
- |||| Trial primary completion date, BRCA Biomarker: Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children (clinicaltrials.gov) - Feb 19, 2015
P3, N=400, Recruiting, Sponsor: Georgetown University
Trial primary completion date: Nov 2014 --> Aug 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- | letrozole / Generic mfg., clomifene citrate / Generic mfg.
Enrollment change: Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome. (clinicaltrials.gov) - Feb 19, 2015
P3, N=140, Recruiting, Sponsor: Cairo University
Trial primary completion date: Dec 2014 --> Dec 2015 N=210 --> 140
- | Phase classification: Mirena in Idiopathic Menorrhagia (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=1125, Completed, Sponsor: Bayer
N=210 --> 140 Phase classification: P4 --> P=N/A
- ||| Clinical: Randomized Clinical Trial on Follicular Flushing in IVF (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=80, Recruiting, Sponsor: University of Luebeck
- || New P2/3 trial: MNZ: Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis (clinicaltrials.gov) - Feb 19, 2015
P2/3, N=64, Completed, Sponsor: Assiut University
- Enrollment closed, Trial initiation date, Surgery: MISSION: Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study (clinicaltrials.gov) - Feb 19, 2015
P2, N=30, Active, not recruiting, Sponsor: Catholic University of the Sacred Heart
Phase classification: P4 --> P=N/A Recruiting --> Active, not recruiting | Initiation date: May 2014 --> Dec 2013
- Trial completion, Preclinical, Trial primary completion date: Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=300, Completed, Sponsor: Cairo University
Recruiting --> Active, not recruiting | Initiation date: May 2014 --> Dec 2013 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2015
- Trial completion, Enrollment change, Trial primary completion date: uropro: Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=1641, Completed, Sponsor: Norwegian University of Science and Technology
Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2015 Recruiting --> Completed | N=2200 --> 1641 | Trial primary completion date: Dec 2016 --> Feb 2014
- triptorelin / Generic mfg.
Trial completion, Trial primary completion date: Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist (clinicaltrials.gov) - Feb 19, 2015
P4, N=120, Completed, Sponsor: AZ Jan Palfijn Gent
Recruiting --> Completed | N=2200 --> 1641 | Trial primary completion date: Dec 2016 --> Feb 2014 Recruiting --> Completed | Trial primary completion date: May 2013 --> Dec 2013
- Climara (estradiol) / Bausch Health, Bayer, Lutrelef (gonadorelin acetate) / Ferring
Trial completion, Enrollment change, Trial primary completion date: Estrogen Sensitivity and Ovulatory Dysfunction in Obesity (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=30, Completed, Sponsor: University of Colorado, Denver
Recruiting --> Completed | Trial primary completion date: May 2013 --> Dec 2013 Active, not recruiting --> Completed | N=20 --> 30 | Trial primary completion date: Oct 2015 --> Jan 2013
- RG 7600 / Roche
Trial primary completion date: A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2015
P1, N=71, Active, not recruiting, Sponsor: Genentech, Inc.
Active, not recruiting --> Completed | N=20 --> 30 | Trial primary completion date: Oct 2015 --> Jan 2013 Trial primary completion date: Feb 2015 --> Jul 2015
- Truseltiq (infigratinib) / BridgeBio, Pfizer, Helsinn, Xediton Pharma
Enrollment change, Trial withdrawal, Trial primary completion date, Combination therapy, Metastases: Ph Ib/BGJ398/Cervix and Other Solid Tumors (clinicaltrials.gov) - Feb 19, 2015
P1, N=0, Withdrawn, Sponsor: The University of Texas Health Science Center at San Antonio
Trial primary completion date: Feb 2015 --> Jul 2015 N=24 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Jan 2015
- sunitinib / Generic mfg.
Enrollment change, Surgery, Metastases: Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery (clinicaltrials.gov) - Feb 19, 2015
P2, N=19, Completed, Sponsor: National Cancer Institute (NCI)
N=24 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Jan 2015 N=32 --> 19
- | cisplatin / Generic mfg., paclitaxel / Generic mfg.
New P2 trial, Surgery, Metastases: 4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery (clinicaltrials.gov) - Feb 19, 2015
P2, N=215, Completed, Sponsor: Campus Bio-Medico University
- | Trial completion, Enrollment change, Trial primary completion date: EMR700623_535: Low-dose Gonal-f (clinicaltrials.gov) - Feb 19, 2015
P4, N=26, Completed, Sponsor: Merck KGaA
N=32 --> 19 Active, not recruiting --> Completed | N=110 --> 26 | Trial primary completion date: Oct 2014 --> Mar 2014
- Removab (catumaxomab) / NeoPharm, Trion Pharma
Trial completion, Enrollment change, Trial primary completion date: Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2015
P2, N=2, Completed, Sponsor: JSehouli
Active, not recruiting --> Completed | N=110 --> 26 | Trial primary completion date: Oct 2014 --> Mar 2014 Recruiting --> Completed | N=51 --> 2 | Trial primary completion date: Jul 2015 --> Feb 2014
- | vinorelbine tartrate / Generic mfg., gemcitabine / Generic mfg.
Trial completion, Trial primary completion date: Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2015
P2, N=44, Completed, Sponsor: The Catholic University of Korea
Recruiting --> Completed | N=51 --> 2 | Trial primary completion date: Jul 2015 --> Feb 2014 Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Oct 2014
- topotecan / Generic mfg., sorafenib / Generic mfg.
Trial completion, Trial primary completion date: TRIAS 2009: Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2015
P2, N=174, Completed, Sponsor: JSehouli
Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Oct 2014 Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Feb 2015
- New P3 trial, Preclinical, Head-to-Head: Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation (clinicaltrials.gov) - Feb 18, 2015
P3, N=40, Recruiting, Sponsor: Invaron Pharmaceuticals Inc.
- letrozole / Generic mfg., clomifene citrate / Generic mfg.
Enrollment open: Ovulation Induction in Clomiphene Citrate Resistant PCO Women (clinicaltrials.gov) - Feb 18, 2015
P0, N=100, Recruiting, Sponsor: Cairo University
Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Feb 2015 Not yet recruiting --> Recruiting
- | progesterone / Generic mfg.
New P4 trial: Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients (clinicaltrials.gov) - Feb 13, 2015
P4, N=120, Not yet recruiting, Sponsor: Instituto Bernabeu
- PF-04691502 / Pfizer, gedatolisib (PF-05212384) / Celcuity
Enrollment change, Trial initiation date: A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer (clinicaltrials.gov) - Feb 13, 2015
P2, N=67, Terminated, Sponsor: Pfizer
Not yet recruiting --> Recruiting N=160 --> 67 | Initiation date: Oct 2011 --> Jan 2012
- ||| Enrollment open: Clinical Evaluation of the BD Onclarity (clinicaltrials.gov) - Feb 11, 2015
P=N/A, N=47000, Recruiting, Sponsor: Becton, Dickinson and Company
N=160 --> 67 | Initiation date: Oct 2011 --> Jan 2012 Withheld --> Recruiting
- Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: Hormonal Contraceptive Use and the Risk of Provoked Vestibulodynia (clinicaltrials.gov) - Feb 10, 2015
P=N/A, N=0, Withdrawn, Sponsor: ahinoam lev sagie
Withheld --> Recruiting N=200 --> 0 | Initiation date: Jan 2013 --> Jan 2012 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2013
- ||| dydrogesterone / Generic mfg.
Trial completion, Observational data: Observational Study of Dydrogesterone in Cycle Regularization (clinicaltrials.gov) - Feb 10, 2015
P=N/A, N=114, Completed, Sponsor: Fudan University
N=200 --> 0 | Initiation date: Jan 2013 --> Jan 2012 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2013 Recruiting --> Completed
- Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial primary completion date, Metastases: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Feb 10, 2015
P2, N=299, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Trial primary completion date: Mar 2015 --> Aug 2015
- New P1 trial, Preclinical: Low-dose GH Supplementation Increases Clinical Pregnancy Rate (clinicaltrials.gov) - Feb 10, 2015
P1, N=70, Recruiting, Sponsor: Centro de Infertilidad y Reproducción Humana
- Preclinical: Use of IMSI in Poor Responders to IVF (clinicaltrials.gov) - Feb 9, 2015
P=N/A, N=200, Recruiting, Sponsor: Centro de Infertilidad y Reproducción Humana
- ||| azithromycin / Generic mfg.
Enrollment closed: RESCUE: Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Feb 9, 2015
P4, N=400, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: Mar 2015 --> Aug 2015 Enrolling by invitation --> Active, not recruiting
- Preclinical: Management of Abnormally Fertilized Zygotes? InVitro Correction of 3PN (clinicaltrials.gov) - Feb 9, 2015
P0, N=22, Enrolling by invitation, Sponsor: Ahmad Mustafa Mohamed Metwalley
- || Enrollment change, Trial primary completion date: Mirena Observational Program (clinicaltrials.gov) - Feb 6, 2015
P=N/A, N=2680, Active, not recruiting, Sponsor: Bayer
Enrolling by invitation --> Active, not recruiting N=187 --> 2680 | Trial primary completion date: Jan 2014 --> Apr 2014
- ||| Enrollment open, Trial primary completion date: Evaluation of Enhanced Syphilis Screening Among HIV-positive Men (clinicaltrials.gov) - Feb 6, 2015
P=N/A, N=3131, Recruiting, Sponsor: Ontario HIV Treatment Network
N=187 --> 2680 | Trial primary completion date: Jan 2014 --> Apr 2014 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2016 --> Jul 2017
- || Avastin (bevacizumab) / Roche
Trial primary completion date: BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer (clinicaltrials.gov) - Feb 6, 2015
P=N/A, N=100, Recruiting, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2016 --> Jul 2017 Trial primary completion date: Dec 2016 --> Jun 2017
- || Trial primary completion date, BRCA Biomarker: Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer (clinicaltrials.gov) - Feb 6, 2015
P=N/A, N=1905, Recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Trial primary completion date: Dec 2016 --> Jun 2017 Trial primary completion date: Jul 2015 --> Jul 2016
- Trial primary completion date: Simple Versus Radical Hysterectomy for Stage I Cervical Cancer (clinicaltrials.gov) - Feb 6, 2015
P=N/A, N=96, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jul 2015 --> Jul 2016 Trial primary completion date: Jan 2016 --> Jan 2017
- ||| Surgery: Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients (clinicaltrials.gov) - Feb 6, 2015
P=N/A, N=110, Not yet recruiting, Sponsor: The Cleveland Clinic
- Preclinical, Trial primary completion date: Endometrial Scratching in In Vitro Fertilization Cycles With Oocyte Donation (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=200, Recruiting, Sponsor: Centro de Infertilidad y Reproducción Humana
Trial primary completion date: Jan 2016 --> Jan 2017 Trial primary completion date: Oct 2015 --> Jan 2016
- anastrozole / Generic mfg.
Trial primary completion date: Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence (clinicaltrials.gov) - Feb 5, 2015
P4, N=70, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Trial primary completion date: Oct 2015 --> Jan 2016 Trial primary completion date: Dec 2013 --> Jul 2015
- Trial primary completion date: Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure (clinicaltrials.gov) - Feb 5, 2015
P4, N=100, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Trial primary completion date: Dec 2013 --> Jul 2015 Trial primary completion date: Jan 2014 --> May 2015
- Firmagon (degarelix) / Astellas, Ferring
Trial primary completion date: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) (clinicaltrials.gov) - Feb 5, 2015
P3, N=80, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Trial primary completion date: Jan 2014 --> May 2015 Trial primary completion date: Oct 2014 --> Jun 2015
- triptorelin / Generic mfg.
Phase classification: GTMLPSGI: GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT (clinicaltrials.gov) - Feb 5, 2015
P3, N=328, Recruiting, Sponsor: Centre Hospitalier Universitaire Ibn Rochd
Trial primary completion date: Oct 2014 --> Jun 2015 Phase classification: P4 --> P3
- || New P3 trial: Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes (clinicaltrials.gov) - Feb 5, 2015
P3, N=200, Recruiting, Sponsor: Royan Institute
- Enrollment closed, Trial primary completion date: A Safety and Tolerability of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial Neoplasia (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: Covidien, GI Solutions
Phase classification: P4 --> P3 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Sep 2015
- Enrollment closed: AIN: A Trial of Radiofrequency Ablation for Anal Intraepithelial Neopplasia Using the HALO Ablation System (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=22, Active, not recruiting, Sponsor: Covidien, GI Solutions
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Sep 2015 Recruiting --> Active, not recruiting
- danazol oral / Generic mfg.
Trial primary completion date: Danazol Treatment in Endometriosis Women Before IVF (clinicaltrials.gov) - Feb 5, 2015
P4, N=150, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2014 --> Apr 2015
- || Trial primary completion date: Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=170, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Trial primary completion date: Jan 2014 --> Apr 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Biomarker, Enrollment change: Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation (clinicaltrials.gov) - Feb 5, 2015
P2, N=20, Completed, Sponsor: CONRAD
Trial primary completion date: Dec 2014 --> Dec 2015 N=39 --> 20
- IDC-G305 / Merck (MSD)
Enrollment closed, Trial primary completion date, Metastases: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer (clinicaltrials.gov) - Feb 5, 2015
P1, N=30, Active, not recruiting, Sponsor: Immune Design
N=39 --> 20 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Nov 2014